Evidence map›Paper›PMID 39534964›Full record

ArticleHypertension (Dallas, Tex. : 1979)2025

Exposure to Volatile Organic Compounds and Blood Pressure in NHANES 2011 to 2018.

Katlyn E McGraw, Arce Domingo-Relloso, Daniel W Riggs, Danielle N Medgyesi, Raghavee Neupane, Jeanette A Stingone, Tiffany R Sanchez

Abstract read
In one paragraph

Article in Hypertension (Dallas, Tex. : 1979), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Current hypertension epidemiology and contemporary approaches using the "Real-World Evidence Cycle" framework.Hypertension research : official journal of the Japanese Society of Hypertension · 2026
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Katlyn E McGrawDepartment of Environmental Health Science (K.E.M., A.D.-R., D.N.M., T.R.S.), Columbia University Mailman School of Public Health, New York, NY.ORCID 0000-0003-1143-3920
Arce Domingo-RellosoDepartment of Environmental Health Science (K.E.M., A.D.-R., D.N.M., T.R.S.), Columbia University Mailman School of Public Health, New York, NY.ORCID 0000-0001-6928-8290
Daniel W RiggsChristina Lee Brown Envirome Institute, University of Louisville, KY (D.W.R.).ORCID 0000-0002-3503-0600
Danielle N MedgyesiDepartment of Environmental Health Science (K.E.M., A.D.-R., D.N.M., T.R.S.), Columbia University Mailman School of Public Health, New York, NY.ORCID 0000-0001-8825-5750
Raghavee NeupaneDr. Kiran C. Patel College of Osteopathic Medicine, Nova Southeastern University, Fort Lauderdale, FL (R.N.).
Jeanette A StingoneDepartment of Epidemiology (J.A.S.), Columbia University Mailman School of Public Health, New York, NY.
Tiffany R SanchezDepartment of Environmental Health Science (K.E.M., A.D.-R., D.N.M., T.R.S.), Columbia University Mailman School of Public Health, New York, NY.ORCID 0000-0001-8601-307X

Funding

Clinical and Translational Science AwardUL1TR001873 · NCATS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI REILLY, MUREDACH P · 2016 to 2025
$99.0M
True Metal fac coreP30ES009089 · NIEHS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Steven N. Chillrud · 1998 to 2026
$44.7M
Superfund Training CoreP42ES023716 · NIEHS · UNIVERSITY OF LOUISVILLE · PI HEIN, DAVID W · 2017 to 2025
$18.1M
Institutional Career Development CoreKL2TR001874 · NCATS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI GENKINGER, JEANINE M., SHIMBO, DAICHI · 2016 to 2025
$13.6M
Supplemental Training in Making Data FAIR and AI/ML ReadyT32ES007322 · NIEHS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Pam R Factor-Litvak, Allison Kupsco · 2000 to 2026
$12.1M
Research Experience and Training Coordination CoreP42ES033719 · NIEHS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Ana Navas-Acien · 2022 to 2026
$11.9M
Metal Exposure and Early Cardiovascular Risk in Adult E-Cigarette UsersR01ES029967 · NIEHS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI NAVAS-ACIEN, ANA, SHIMBO, DAICHI · 2020 to 2024
$3.4M
NCATS NIH HHS KL2 TR001874NCATS NIH HHS UL1 TR001873NIEHS NIH HHS P30 ES009089NIEHS NIH HHS P42 ES023716NIEHS NIH HHS P42 ES033719NIEHS NIH HHS R01 ES029967NIEHS NIH HHS T32 ES007322
6 · The paper itself

Abstract

backgroundVolatile organic compounds (VOCs) are ubiquitous environmental pollutants. Exposure to VOCs is associated with cardiovascular disease risk factors, including elevated blood pressure in susceptible populations. However, research in the general population, particularly among nonsmoking adults, is limited. We hypothesized that higher VOC exposure is associated with higher blood pressure and hypertension, among nonsmokers.

methodsWe included 4 cycles of data (2011-2018) of nonsmoking adults (n=4430) from the National Health and Nutrition Examination Survey. Urinary VOC metabolites were measured by ultraperformance liquid chromatography-mass spectrometry, adjusted for urine dilution, and log-transformed. We estimated mean differences in blood pressure using linear models and prevalence ratio of stage 2 hypertension using modified Poisson models with robust standard errors. Models were adjusted for age, sex, race and ethnicity, education, body mass index, estimated glomerular filtration rate, and National Health and Nutrition Examination Survey cycle.

resultsParticipants were 54% female, with a median age of 48 years, 32.3% had hypertension, and 7.9% had diabetes. The mean differences (95% CI) in systolic blood pressure were 1.61 (0.07-3.15) and 2.46 (1.01-3.92) mm Hg when comparing the highest with the lowest quartile of urinary acrolein (N-acetyl-S-[2-carboxyethyl]-L-cysteine) and 1,3-butadiene (N-acetyl-S-[3,4-dihydroxybutyl]-L-cysteine) metabolites. The prevalence ratios for hypertension were 1.06 (95% CI, 1.02-1.09) and 1.05 (95% CI, 1.01-1.09) when comparing the highest with lowest quartiles of urinary acrolein (N-acetyl-S-[2-carboxyethyl]-L-cysteine) and 1,3-butadiene (N-acetyl-S-[3,4-dihydroxybutyl]-L-cysteine), respectively.

conclusionsExposure to VOCs may be a relevant yet understudied environmental contributor to cardiovascular disease risk in the nonsmoking, US population.

Indexed as

Blood PressureHypertensionNutrition SurveysVolatile Organic CompoundsAdultButadienesEnvironmental ExposureFemaleHumansMaleMiddle AgedPrevalenceUnited States1,3-butadieneButadienesVolatile Organic Compoundsacroleinblood pressurecardiovascular diseaseshypertensionvolatile organic compounds

Identifiers

PMID39534964
PMCPMC11655251

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.